Your browser doesn't support javascript.
loading
Sotagliflozin, a Dual SGLT1/2 Inhibitor, Improves Cardiac Outcomes in a Normoglycemic Mouse Model of Cardiac Pressure Overload.
Young, Sophia L; Ryan, Lydia; Mullins, Thomas P; Flint, Melanie; Steane, Sarah E; Walton, Sarah L; Bielefeldt-Ohmann, Helle; Carter, David A; Reichelt, Melissa E; Gallo, Linda A.
Afiliación
  • Young SL; School of Biomedical Sciences, The University of Queensland, St Lucia, QLD, Australia.
  • Ryan L; Mater Research Institute-University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
  • Mullins TP; School of Biomedical Sciences, The University of Queensland, St Lucia, QLD, Australia.
  • Flint M; Mater Research Institute-University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
  • Steane SE; School of Biomedical Sciences, The University of Queensland, St Lucia, QLD, Australia.
  • Walton SL; Mater Research Institute-University of Queensland, Translational Research Institute, Woolloongabba, QLD, Australia.
  • Bielefeldt-Ohmann H; School of Biomedical Sciences, The University of Queensland, St Lucia, QLD, Australia.
  • Carter DA; School of Biomedical Sciences, The University of Queensland, St Lucia, QLD, Australia.
  • Reichelt ME; Cardiovascular Disease Program, Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Gallo LA; School of Veterinary Science, The University of Queensland, Gatton, QLD, Australia.
Front Physiol ; 12: 738594, 2021.
Article en En | MEDLINE | ID: mdl-34621187

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Physiol Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Physiol Año: 2021 Tipo del documento: Article País de afiliación: Australia